In-person clinical trials have been essential for medical researchers. Participants would travel to hospitals or research centers, fill out paperwork, and meet one-on-one with clinicians — until the coronavirus pandemic impeded those efforts. Many clinical trials have since become virtual, which may be considered advantageous, as more people can partake without the hassles. In fact, Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, believes online trials may be here to stay. To read the full story.
- New NJACTS Publication
- NJACTS Community Engagement Core COVID-19 Resources
- People Living with HIV Need Tailored COVID-19 Vaccination Information.
- How the Pandemic Limited Access to Opioid Addiction Treatment for Racial and Ethnic Minority Groups.
- Parental Depression Screening Beyond the Postpartum Period has the Potential to Identify Families Needing Support.